Author

Anne-Christine Bay-Jensen 1

1 Nordic Bioscience A/S,Herlev,Denmark

A NEO-EPITOPE SPECIFIC BIOMARKER OF FIBROSIS RESOLUTION - DETECTION OF PROTEASE DEGRADED, AND CROSS-LINKED TYPE III COLLAGEN DEGRADATION METABOLITES RELEASED WITH FIBROLYSIS

Martin Pehrsson, Morten Asser Karsdal, Mette Juul Fisker Nielsen, Keyur Patel, Zachary Goodman, Anne-Christine Bay-Jensen, Diana Julie Leeming, Joachim Høg Mortensen

BIOMARKERS REFLECTING EXTRACELLULAR MATRIX TURNOVER AND INFLAMMATION CAN BE USED TO MONITOR DISEASE ACTIVITY AND TREATMENT RESPONSE IN PATIENTS WITH CROHN’S DISEASE UNDERGOING INFLIXIMAB INDUCTION THERAPY

Marta Sorokina Alexdóttir, Arno R. Bourgonje, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Klaas Nico Faber, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Gerard Dijkstra, Joachim Mortensen

HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN’S DISEASE

Joachim Høg Mortensen, Morten Asser Karsdal, Christian Lodberg Hvas, Anders Kirch Dige, Henning Grønbæk, Anne-Christine Bay-Jensen

INCREASED EXTRACELLULAR MATRIX PROTEINS TURN-OVER IN PATIENTS WITH CROHN’S DISEASE

Line Godskesen, Michael Dam Jensen, Lone Gabriels Klinge, Joachim Mortensen, Anne-Christine Bay-Jensen, Aleksander Krag

NEO-EPITOPE PROTEIN FRAGMENT OF CALPROTECTIN DERIVED FROM HUMAN NEUTROPHIL ELASTASE (CPA9-HNE) IS A NOVEL SERUM CALPROTECTIN BIOMARKER OF INFLAMMATION AND DISEASE ACTIVITY FOR IBD

Patrik Önnerfjord, Joachim Høg Mortensen, Dovile Sinkeviciute, Marko Brinar, Viktor Domislovic, Tina Manon-Jensen, Morten Asser Karsdal, Zeljko Krznaric, Anne-Christine Bay-Jensen

NON-INVASIVE BIOMARKERS OF TYPE III COLLAGEN CROSS-LINKING REFLECT FIBROLYSIS IN CROHN'S DISEASE PATIENTS WITH A NON-STRICTURING AND NON-PENETRATING DISEASE BEHAVIOUR

Martin Pehrsson, Line Elberg Godskesen, Anne-Christine Bay-Jensen, Morten Asser Karsdal, Aleksander Krag, jens kjeldsen, Joachim Høg Mortensen

NOVEL SEROLOGICAL BIOMARKERS FOR MONITORING DISEASE PROGRESSION IN ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS

Martin Pehrsson, Willemijn E. de Rooij, Joachim Høg Mortensen, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Albert J. Bredenoord

PLATELET ACTIVATION BY ACTIVATED VON WILLEBRAND FACTOR IS A MARKER OF INTESTINAL WOUND HEALING IN PATIENTS WITH CROHN'S DISEASE

Lasse Langholm, Tina Manon-Jensen, Shu Sun, Joachim Høg Mortensen, Yi He, Aleksander Krag, Michael Dam Jensen, Anne-Christine Bay-Jensen, jens kjeldsen, Morten Karsdal

SEROLOGICAL BIOMARKERS OF TYPE III AND IV COLLAGEN REMODELING PREDICT AND MONITOR INFLIXIMAB TREATMENT RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Marta Sorokina Alexdóttir, Arno R. Bourgonje, Anne-Christine Bay-Jensen, Klaas Nico Faber, Morten Asser Karsdal, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Gerard Dijkstra, Joachim Mortensen

TOFACITINIB AND CYTOKINES OF THE JAK SIGNALING PATHWAY PROTECT AGAINST EXTRACELLULAR MATRIX (ECM) DESTRUCTION IN AN INTESTINAL EX VIVO MODEL

Martin Pehrsson, Majken Lindholm, Tina Manon-Jensen, Aleksander Krag, Morten Asser Karsdal, jens kjeldsen, Anne-Christine Bay-Jensen, Joachim Høg Mortensen

Item 1 - 10 / 12
1
2